Marathon Petroleum Total Cost of Revenue increased by 8.3% to $31.26B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 6.5%, from $29.36B to $31.26B. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows relatively stable performance with a 2.1% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $27.18B | $29.56B | $32.18B | $35.07B | $44.21B | $38.82B | $33.58B | $29.29B | $31.76B | $34.93B | $32.58B | $29.59B | $33.95B | $32.14B | $30.56B | $29.36B | $30.03B | $31.20B | $28.86B | $31.26B |
| QoQ Change | — | +8.8% | +8.9% | +9.0% | +26.1% | -12.2% | -13.5% | -12.8% | +8.4% | +10.0% | -6.7% | -9.2% | +14.7% | -5.3% | -4.9% | -3.9% | +2.3% | +3.9% | -7.5% | +8.3% |
| YoY Change | — | — | — | — | +62.7% | +31.3% | +4.3% | -16.5% | -28.2% | -10.0% | -3.0% | +1.0% | +6.9% | -8.0% | -6.2% | -0.8% | -11.5% | -2.9% | -5.6% | +6.5% |